Immucell Corp Stock
Your prediction
Immucell Corp Stock
The Immucell Corp stock is trending slightly upwards today, with an increase of €0.050 (0.890%) compared to yesterday's price.
Pros and Cons of Immucell Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immucell Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immucell Corp | 0.890% | 1.786% | 14.000% | 17.769% | 11.765% | -17.391% | 10.680% |
| Vaxart Inc. | - | -25.000% | 65.198% | -37.587% | 60.714% | -54.765% | -92.683% |
| Larimar Therapeutics Inc. | -4.320% | -6.338% | -8.276% | -14.744% | -19.880% | -36.967% | -83.375% |
| aTyr Pharma Inc | - | 11.538% | 16.000% | -83.978% | -3.333% | -72.142% | -82.424% |
News
ImmuCell Q2 Profit Jumps as Margins Rise
ImmuCell(NASDAQ:ICCC) reported results for the three-month period ended June 30, 2025, on August 14, 2025, highlighting a sharp rebound in profitability with adjusted EBITDA of $1.43 million
ImmuCell Posts 18% Gain in Q2
ImmuCell (NASDAQ:ICCC), a specialist in animal health products for the dairy and beef industries, issued its earnings results for the second quarter of fiscal 2025 on August 14, 2025. The company